Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02WGN
|
||||
Former ID |
DIB009180
|
||||
Drug Name |
YM-114
|
||||
Synonyms |
KAE-393; (R)-5-(2,3-Dihydro-1H-indol-1-ylcarbonyl)-4,5,6,7-tetrahydro-1H-benzimidazole hydrochloride
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Nausea [ICD10:R11] | Discontinued in Phase 2 | [545300] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H18ClN3O
|
||||
Canonical SMILES |
C1CC2=C(CC1C(=O)N3CCC4=CC=CC=C43)NC=N2.Cl
|
||||
InChI |
1S/C16H17N3O.ClH/c20-16(12-5-6-13-14(9-12)18-10-17-13)19-8-7-11-3-1-2-4-15(11)19;/h1-4,10,12H,5-9H2,(H,17,18);1H/t12-;/m1./s1
|
||||
InChIKey |
GZXONPGTMHLBKQ-UTONKHPSSA-N
|
||||
CAS Number |
CAS 132036-91-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine receptor 3A | Target Info | Antagonist | [534150], [551871] | |
KEGG Pathway | Serotonergic synapse | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
PANTHER Pathway | 5HT3 type receptor mediated signaling pathway | ||||
Reactome | Ligand-gated ion channel transport | ||||
WikiPathways | SIDS Susceptibility Pathways | ||||
Iron uptake and transport | |||||
References | |||||
Ref 534150 | Effect of serotonin (5-HT)3-receptor antagonists YM060, YM114 (KAE-393), ondansetron and granisetron on 5-HT4 receptors and gastric emptying in rodents. Jpn J Pharmacol. 1995 Nov;69(3):205-14. | ||||
Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.